Differential Efficacy of Weight Loss Interventions in Patients with Versus Without Diabetes

被引:1
|
作者
Losada-Diaz, Federico [1 ]
Lizarazo-Bocanegra, Santiago [1 ]
Perdomo-Lugo, Juan J. [1 ]
Gutierrez-Romero, Sebastian A. [1 ]
Correa-Osio, Isabella [1 ]
Mendivil, Carlos O. [1 ,2 ]
机构
[1] Univ Andes, Sch Med, Bogota, Colombia
[2] Fdn Santa Fe Bogota, Dept Internal Med, Sect Endocrinol, Bogota, Colombia
关键词
Obesity; Diabetes; Weight loss; GLP-1; agonists; Bariatric surgery; OBESE-PATIENTS; BODY-WEIGHT; BARIATRIC SURGERY; RECEPTOR AGONISTS; TYPE-2; OVERWEIGHT; ADULTS; LIRAGLUTIDE; SEMAGLUTIDE; LIFE;
D O I
10.1007/s13300-024-01646-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obesity is both a major risk factor for diabetes and a serious comorbidity of the condition. The twin epidemics of obesity and diabetes have spread globally over the past few decades. Treatment of obesity in patients with diabetes provides a host of clinical benefits that encompass virtually all body systems. Despite this, multiple lines of evidence suggest that the efficacy of most therapies for weight loss is significantly reduced among patients with diabetes. With this background, we summarize the evidence of a differential effect of lifestyle, pharmacological, and surgical treatments for obesity in patients with existing diabetes, and explore the potential mechanisms involved in this phenomenon. This information is then used to formulate strategies to improve weight loss outcomes for patients with diabetes.
引用
收藏
页码:2279 / 2291
页数:13
相关论文
共 50 条
  • [21] Use of exenatide for weight loss in patients with diabetes
    Virji, Ayaz
    AMERICAN FAMILY PHYSICIAN, 2007, 75 (09) : 1304 - 1304
  • [22] Bariatric surgery-induced weight loss in patients with and without type 2 diabetes mellitus
    Carvalho, Thatiany A.
    Ronsoni, Marcelo F.
    Hohl, Alexandre
    van de Sande-Lee, Simone
    CLINICAL OBESITY, 2020, 10 (02)
  • [23] Weight Loss Outcomes With and Without Diabetes in Patients With NAFLD in a Specialty Fatty Liver Disease Program
    Ilagan-Ying, Ysabel C.
    Valido, Kailyn
    Chehayeb, Rachel Jaber
    Bollinger, Bryan
    Mehal, Wajahat
    Do, Albert
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S967 - S968
  • [24] Intramyocellular lipids (IMCL) in obese patients with and without type 2 diabetes: Effects of weight loss
    Berk, E
    Shen, W
    Mao, XL
    Shungu, D
    Pi-Sunyer, X
    Ravussin, E
    Albu, J
    OBESITY RESEARCH, 2005, 13 : A11 - A12
  • [25] Q: Should I consider metformin therapy for weight loss in patients with obesity but without diabetes?
    Rodriguez, Paloma
    Pantalone, Kevin M.
    Griebeler, Marcio L.
    Burguera, Bartolome
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2023, 90 (09) : 545 - 548
  • [27] Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: A systematic review and meta-analysis of randomized controlled trials
    Gao, Xueqin
    Hua, Xiaoli
    Wang, Xu
    Xu, Wanbin
    Zhang, Yu
    Shi, Chen
    Gu, Ming
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [28] Effects of exenatide versus placebo on weight loss in patients with type 2 diabetes according to dietary
    Glass, L.
    Wolka, L.
    Guo, Y.
    Qu, Y.
    Bonnard, C.
    Salaun-Martin, C.
    DIABETES & METABOLISM, 2009, 35 : A8 - A9
  • [29] Comparing Diabetes Outcomes Weight-independent Effects of Sleeve Gastrectomy Versus Matched Patients With Similar Weight Loss
    Yang, Phillip
    Bonham, Aaron J.
    Ghaferi, Amir A.
    Varhan, Oliver A.
    ANNALS OF SURGERY, 2022, 275 (05) : 924 - 927
  • [30] Mind the gap: efficacy versus effectiveness of lifestyle interventions to prevent diabetes
    Wareham, Nicholas J.
    LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (03): : 160 - 161